This decline correlates with many aging markers: Body composition changes: Increasing fat mass, particularly visceral fat, with decreasing lean muscle mass
Clinical studies have supported the use of AOD-9604 for weight loss in animal subjects, and while some human trials have shown promising results for fat burning, the extent of its effectiveness can vary among individuals
Researchers who have experience with tirzepatide compound dosage charts will find the retatrutide math very familiar
Importantly, AOD-9604 does not bind to growth hormone receptors, which is why it lacks the glucose-elevating and IGF-1-stimulating effects of full-length growth hormone
Minimize time outside refrigeration, disinfect stoppers before every use, and use new sterile needles for each draw to maximize viable storage time
Store lyophilized vials in the original amber glass or dark packaging, away from any direct or indirect light source including natural window light